Industry WatchGear And Accessories
Immatics Reports $79.8 Million Q2 Loss
German biotech posts revenue of $5.4 million in quarter
📅
✍️By ZRIntel Editorial Team📍Tubingen, Germany
TUBINGEN, Germany Immatics N.V. (IMTX) reported a Q2 loss of $79.8 million, or 66 cents per share, on revenue of $5.4 million. The biotech is investing heavily in cancer immunotherapy development.